Connect Biopharma Hldgs (CNTB) Stock Price, Quote, News & History | Benzinga

SPY778.57+0.60%QQQ751.38+0.51%BTC/USD83,452.01+0.64%DIA516.21+0.89%GLD384.50+1.55%TLT77.97+0.12%

Connect Biopharma Holdings Ltd (CNTB) Stock Price, Quote, News & History

CNTBNASDAQ

Trade with Public

Trade with Public

$0.8700

-0.0107-1.21%

Last update: Oct 9, 6:39 PM

$0.9001

0.01942.2%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$0.87

Close

$0.87

Volume / Avg.

1.05M / 3.75M

Day Range

$0.90 - $0.90

52 Wk Range

0.85 - 3.82

Market Cap

$55.46M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

32

Short Interest

7.88%

Days to Cover

1

Recent Connect Biopharma Holdings Ltd News

Crude Oil Rises Over 1%; Conagra Brands Earnings Top Views

U.S. stocks mixed: Dow fell over 200 points, while Nasdaq and S&P 500 rose; inflation cooled and Q2 GDP was revised higher.

Avi Kapoor

Connect Biopharma Reports Significant Drop In Treatment Failure With New COPD Therapy

Connect Biopharma reports positive Phase 2 results for rademikibart, showing an 81% reduction in COPD treatment failure and high safety.

Vandana Singh

Nasdaq Gains Over 100 Points; Jabil Posts Upbeat Earnings

U.S. stocks rose, led by tech, as Jabil beat Q4 estimates and raised FY2027 guidance; oil and gold also climbed.

Avi Kapoor

Why Is Connect Biopharma Stock Trading Lower on Tuesday?

Connect Biopharma asthma drug rademikibart misses primary endpoint but shows improved lung function and a favorable safety profile.

Vandana Singh

This Lear Analyst Turns Bullish; Here Are Top 4 Upgrades For Tuesday

Top Wall Street analysts upgraded LEA, BAH, TRV, and CGNX stocks, with higher price targets. See what analysts think of other stocks on rating page.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-60.58M

Investing Cash Flow (TTM)

26.86M

Financing Cash Flow (TTM)

19.88M

Free Cash Flow (TTM)

-60.63M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-13.84M

Analyst Trends and Forecast

2

May

2

Jun

1

Jul

5

Sep

2

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$23.90M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

17.74

PB Ratio (TTM)

2.12

Earnings Yield % (TTM)

-131.30%

Earnings Yield % (FWD)

-73.93%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.43

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$27.02M

Debt to Equity

0.02

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-